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 Abstract  29 
Endurance exercise improves cardiac performance and affords protection against cardiovascular diseases but 30 
the signalling events that mediate these benefits are largely unexplored. Phosphorylation is an widely studied 31 
post-translational modification involved in intracellular signalling, and to discover novel phosphorylation 32 
events associated with exercise we have profiled the cardiac phosphoproteome response to a standardised 33 
exercise test to peak oxygen uptake (VO2peak). 34 
Male Wistar rats (346 ± 18 g) were assigned to 3 independent groups (n= 6, in each) that were familiarised 35 
with running on a motorised treadmill within a metabolic chamber. Animals performed a graded exercise test 36 
and were killed either immediately (0 h) after or 3 h after terminating the test at a standardised physiological 37 
end point (i.e. peak oxygen uptake; VO2peak). Control rats were killed at a similar time of day to the 38 
exercised animals, to minimise possible circadian effects. Cardiac proteins were digested with trypsin and 39 
phosphopeptides were enriched by selective binding to titanium dioxide (TiO2). Phosphopeptides were 40 
analysed by liquid chromatography and high-resolution tandem mass spectrometry, and phosphopeptides were 41 
quantified by MS1 intensities and identified against the UniProt knowledgebase using MaxQuant (data are 42 
available via ProteomeXchange, ID PXD006646).  43 
The VO2peak of  rats in the 0 h and 3 h groups was 66 ± 5 ml•kg-1•min-1 and 69.8 ± 5 ml•kg-1•min-1, 44 
respectively.  Proteome profiling detected 1169 phosphopeptides and one-way ANOVA found 141 significant 45 
(P<0.05 with a false discovery rate of 10 %) differences. Almost all (97 %) of the phosphosites that were 46 
responsive to exercise are annotated in the PhosphoSitePlus database but, importantly, the majority of these 47 
have not previously been associated with the cardiac response to exercise. More than two-thirds of the 48 
exercise-responsive phosphosites were different from those identified in previous phosphoproteome profiling 49 
of the cardiac response to β1-adrenergic receptor stimulation. Moreover, we report entirely new 50 
phosphorylation sites on 4 cardiac proteins, including S81 of muscle LIM protein, and identified 7 exercise-51 
responsive kinases, including myofibrillar protein kinases such as obscurin, titin and the striated-muscle-52 
specific serine/threonine kinase (SPEG) that may be worthwhile targets for future investigation.  53 
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 1. Introduction 63 
Exercise has an irrefutable role in preventing heart failure and cardiac diseases, for example acute exercise has 64 
cardio-protective effects similar to ischaemic preconditioning {Frasier 2011} and chronic exercise training 65 
results in physiological cardiac hypertrophy {Bernardo 2016} and a heart phenotype that affords protection 66 
against pathological insults such as ischaemia/reperfusion injury {Powers 2008}. Although the physiological 67 
benefits of exercise are clear, less is known about the molecular mechanisms that underlie these effects. Yet 68 
greater molecular understanding could enable the benefits of exercise to be further optimised or personalised 69 
and could suggest new targets for more effective modes of diagnosis, prevention or rehabilitation of 70 
debilitating cardiac diseases.  71 
Previous work has investigated discrete signalling events activated in response to exercise, for example in the 72 
context of acute cardiac preconditioning {Frasier 2011} or adaptive versus maladaptive cardiac 73 
hypertrophy{Bernardo 2016}. The IGF-1 receptor/PI3K (p110α)/ Akt1 pathway is perhaps the most well-74 
explored regulatory pathway associated with exercise-induced cardiac hypertrophy but it is unlikely that a 75 
biological phenomenon as complex as cardiac growth is entirely mediated by a single pathway and more often 76 
integrated networks of molecules across multiple pathways are required to achieve physiological adaptations 77 
to environmental stimuli {Bhalla 1999}. Therefore, events outside of the canonical IGF-1R/ PI3K(p110α)/ 78 
Akt1 pathway are likely to also contribute to exercise-induced cardiac adaptations and remain to be 79 
discovered.  80 
Vigorous exercise is associated with significant elevations in cardiac work and myocardial contractility which 81 
are driven by the chronotropic and inotropic effects of beta-adrenergic receptor (AR) signalling (sympathetic 82 
drive) as well as local metabolic responses and mechanical strain. In addition to driving acute increases in 83 
cardiac output, the molecular events associated with exercise also instigate adaptive processes that alter the 84 
cardiac proteome {Burniston 2009} and increase the capacity for work (i.e. VO2peak). Phosphorylation 85 
networks are recognised widely in the literature and are known to transduce signals involved in the skeletal 86 
muscle response to exercise in humans {Hoffman 2015} but until now the cardiac phosphoproteome response 87 
to exercise has not been reported. Phosphoproteome profiling is a useful approach to discover the pathways 88 
and signalling events involved in physiological processes, and a key advantage of this technique is its non-89 
 targeted approach that it is not biased by preconceptions about which pathways or events may be of greatest 90 
importance.  91 
Due to the implausibility of sampling human cardiac tissue in the context of exercise physiology, models are 92 
required that simulate exercise prescription in humans while allowing access to the heart for molecular 93 
investigation. The exercise stimulus is a composite of 3 inter-related variables, i.e. exercise intensity, duration 94 
and frequency, and the cardio-protective of exercise is intensity-dependent {Frasier 2011}. Therefore, to 95 
control and standardise exercise intensity we {Burniston 2009} have used indirect calorimetry and an 96 
incremental protocol of exercise on a motorised treadmill to measure peak oxygen uptake (VO2peak) of rats 97 
in a manner that is equivalent to best practice in human studies (e.g. {Holloway 2009}). During the VO2peak 98 
test the animal’s respiratory gases are monitored and the test is terminated when the animal reaches its peak 99 
aerobic capacity (this intensity of exercise is attainable even by previously sedentary animals). By using this 100 
physiological end-point we minimise the influence of acute stress induced by an unrealistic exercise load. 101 
Such, standardisation is important because differences in exercise capacity exist even within a colony of 102 
animals exposed to identical environmental conditions. Therefore, exposure to the same relative exercise 103 
stimulus represents an optimised model with the best chances of successfully identifying the key regulatory 104 
networks that mediate exercise-induced adaptation. 105 
106 
 2. Methods 107 
2.1. Graded treadmill test of peak oxygen uptake 108 
Experiments were conducted under the British Home Office Animals (Scientific Procedures) Act 1986 and 109 
according to UK Home Office guidelines. Male Wistar rats were bred in-house in a conventional colony and 110 
the environmental conditions controlled at 20 ± 2 °C, 45-50% humidity with a 12-h light (1800-0600) and 111 
dark cycle. Water and food (containing 18. 5% protein) were available ad libitum.  112 
Exercise sessions were conducted during the animals’ dark period. All rats (n = 18) completed a 14-day 113 
familiarization procedure encompassing daily bouts (15 min duration) at various belt speeds and inclines on a 114 
motorized treadmill within a metabolic chamber (Columbus Instruments, OH). On the 15th day the VO2peak 115 
of animals (n= 12) assigned to the exercise groups was measured using an incremental test, as described 116 
previously {Burniston 2009; Burniston 2008}. Briefly, a warm-up (5 min running at 6 m•min-1, 0° incline) 117 
was completed followed a series of 3 min stages of alternating increases in speed (increments of 2 m•min-1) 118 
and incline (increments of 5°; maximum incline 25°). Air pumped (2.5 l•min-1) through the chamber was 119 
analysed for concentrations of oxygen and carbon dioxide (Oxymax system; Columbus Instruments, OH; 120 
calibrated to an external standard) and a metal grid at the rear of the treadmill belt, which delivered a 121 
maximum of 3 electric stimuli (0.1 mA, 0.3 s duration), was used to encourage the animals to achieve their 122 
VO2peak. Independent groups (n = 6, in each) of animals were killed by cervical dislocation either 123 
immediately (0 h) after cessation of the exercise test or 3 h after completing the exercise test. Hearts were 124 
isolated from the exercised animals and from control rats (n = 6) that completed the familiarization training 125 
but did not perform an incremental exercise test. Hearts were rapidly isolated, cleaned and weighed before 126 
being stored at -80 °C. To minimize the influence of circadian differences, control rats were killed at a time of 127 
day coinciding with the incremental exercise test. 128 
 129 
2.2. Sample preparation 130 
Left ventricles were pulverized in liquid nitrogen and an accurately weighed portion (100 mg) homogenized 131 
on ice in 10 volumes of 8 M urea, 4% w/v CHAPS, 40 mM Tris base including protease and phosphatase 132 
inhibitor cocktails (Roche Diagnostics, Lewes, UK) at 4 ºC. After centrifugation at 20,000 g, 4 ºC for 45 min 133 
 the supernatant was decanted and the protein concentration measured using a modified ‘microtitre plate’ 134 
version of the Bradford assay (Sigma, Poole, Dorset, UK).  135 
Aliquots containing 2 mg protein were reduced with 2.5 mM dithiothreitol for 1 h at room temperature then 136 
alkylated with 5 mM iodoacetamide for 45 min in the dark at room temperature. Samples were diluted with 50 137 
mM ammonium bicarbonate to bring the concentration of urea to 1M and sequencing-grade trypsin (Promega) 138 
was added at a substrate to enzyme ratio of 50:1. After 4 h, samples were diluted threefold with 50 mM 139 
ammonium bicarbonate containing additional trypsin, and the digestion was allowed to proceed overnight. 140 
After acidification to a final concentration of 1 % (v/v) formic acid, the peptide solutions were desalted using 141 
disposable Toptip C18 columns (Glygen) and lyophilized to dryness. Phosphopeptides were selectively 142 
enriched by binding to titanium dioxide (TiO2)-coated magnetic beads (Pierce) according to the 143 
manufacturer’s instructions, as described in previously {Guo 2013}. Briefly, peptides were resuspended in 144 
200 µL 80 % acetontirile, 2 % formic acid and incubated for 1 min with 10 µL of slurry containing TiO2 145 
magnetic beads. Unbound peptides and supernatant were decanted and the beads were washed three times 146 
with 200 µL binding buffer (supplied with the kit). After final decanting, the beads were incubated for 10 min 147 
with 30 µL elution buffer and the eluate was carefully removed and dried prior to mass spectrometry analysis. 148 
 149 
2.3. Mass spectrometry analysis 150 
Tryptic peptide mixtures were analysed by nano-scale high-performance liquid chromatography (Proxeon 151 
EASY-Nano system) and online nano electrospray ionization (ESI) tandem mass spectrometry (LTQ-Orbitrap 152 
Velos mass spectrometer; Thermo Fisher Scientific). Samples were loaded in aqueous 0.1% (v/v) formic acid 153 
via a trap column constructed from 25 mm of 75 µm i.d. silica capillary packed with 5 µm Luna C18 154 
stationary phase (Phenomenex). The analytical column was constructed in a 100 mm × 75 µm i.d. silica 155 
capillary packed with 3 µm Luna C18 stationary phase. Mobile phase A, consisted of 5 % acetonitrile and 0.1 156 
% formic acid, and organic phase B contained 95 % acetonitrile and 0.1 % formic acid. Reverse phase 157 
separation was performed over 120 min at a flow rate of 300 nL/min, rising to 6 % B in 1 min then from 6 % 158 
to 24 % B over 89 min followed by a 16 min gradient to 100 % B, which was held for 5 min prior to re-159 
equilibration to 0 % B over 9 min. Eluted peptides were sprayed directly in to an LTQ-Orbitrap Velos mass 160 
 spectrometer using a nanospray ion source (Proxeon). Tandem mass spectrometry (MS/MS) was performed 161 
using high-energy collision-induced disassociation (HCD) and 10 MS/MS data-dependent scans (7,500 162 
resolution) were acquired in centroid mode alongside each profile mode full-scan mass spectra (30,000 163 
resolution), as reported previously {Guo 2013}. The automatic gain control (AGC) for MS scans was 1 x 106 164 
ions with a maximum fill time of 250 ms. The AGC for MS/MS scans was 3 × 104, with 150 ms maximum 165 
injection time, 0.1 ms activation time, and 40% normalized collision energy. To avoid repeated selection of 166 
peptides for MS/MS a dynamic exclusion list was enabled to exclude a maximum of 500 ions over 30 s. 167 
 168 
2.4. Protein identification  169 
Data files (RAW format) were searched using the standard workflow of MaxQuant (version 1.3.0.5; 170 
http://maxquant.org/) against a non-redundant rat protein sequence FASTA file from the UniProt/ SwissProt 171 
database modified to contain porcine trypsin sequences. The search parameters allowed 2 missed cleavages, 172 
carbamidomethylation of cysteine (fixed) and variable oxidation of methionine, protein N-terminal acetylation 173 
and phosphorylation of STY residues. Precursor ion tolerances were 20 ppm for first search and 6 ppm for a 174 
second search. The MS/MS peaks were de-isotoped and searched using a 20 ppm mass tolerance. A stringent 175 
false discovery rate threshold of 1 % was used to filter candidate peptide, protein, and phosphosite 176 
identifications. The mass spectrometry proteomics data have been deposited to the ProteomeXchange 177 
Consortium via the PRIDE {Vizcaíno 2016} partner repository with the dataset identifier PXD006646.  178 
 179 
2.5. Bioinformatic Analysis 180 
Raw intensities were extracted from the MaxQuant evidence files using an in-house Perl script. Briefly, the 181 
intensities from each biological replicate were collapsed to a specific phosphorylation site as opposed to a 182 
specific peptide. The residue number (e.g. S224 – phosphorylation on the 224th residue (serine) of the protein) 183 
was extracted from the FASTA file used for the original MaxQuant protein search and in any given biological 184 
replicate every intensity that can attributed to S224 is summed. If multiple phosphorylations exist on a peptide 185 
then the intensities are counted only for the multi-phosphorylation, i.e. single, double and multi 186 
phosphorylation become different entities and are scored accordingly. Phospho expression sets were 187 
 normalized in R using quantile normalization in the limma package. Each modification was scored for 188 
differential expression using one-way analysis of variance (ANOVA) across the 3 different time points 189 
(control, 0 h and 3 h) complemented by independent t-tests of each pairwise comparison (i.e. 0 h vs control, 190 
and 3 h vs control). The false discovery rate (FDR) was assessed by calculating q values {Storey 2003} from 191 
the p value distribution of the ANOVA outputs. Protein identifiers associated with statistically significant 192 
(P<0.05, FDR <10 %) exercise-responsive phosphopeptides were uploaded to David GO 193 
(https://david.ncifcrf.gov) {Huang 2009; Huang 2009b} for functional annotation and association to KEGG 194 
pathways. Hierarchical clustering was performed using the Graphical Proteomics data Explorer (GProX) 195 
{Rigbolt 2011} and protein interactions were investigating using bibliometric mining in the search tool for the 196 
retrieval of interacting genes/proteins (STRING; http://string-db.org/) {Franceschini 2013}. 197 
 198 
2.6. Western blot analyses 199 
Immuno-detection of selected targets was performed using previously described {Burniston 2014}methods. 200 
Briefly, samples containing 50 µg protein were resolved by denaturing gel electrophoresis and transferred on 201 
to polyvinylidene difluoride membranes. Non-specific protein interactions were blocked by incubating the 202 
membranes with 5 % non-fat dry milk in 20 mM Tris, 150 mM NaCl, and 0.1% Tween 20, pH 7.6 (TBS-T) 203 
for 1 hr at room temperature. Membranes were then washed in TBS-T and incubated overnight with TBS-T 204 
containing 5 % BSA and primary antibodies specific for: p38 mitogen activated protein kinase (p38 MAPK; 205 
9212 Cell Signalling Technology; 1:1,000 dilution) and phosphorylated (T180/Y182) p38 MAPK (9211 Cell 206 
Signalling Technology; 1:1,000 dilution) or alpha B crystallin (CRYAB; ab13497 Abcam; 1:10,000 dilution) 207 
and phosphorylated (S59) CRYAB (ab5577 Abcam; 1:5,000 dilution). Serial washes in TBS-T were per-208 
formed prior to and after incubation with secondary antibodies (goat anti-rabbit IgG; ab205718 Abcam; 209 
1:20,000 dilution) in 5 % BSA in TBS-T for 2 h followed by enhanced chemiluminescence (ECL Prime; GE 210 
Healthcare) and digitization (Gel Doc XRS; Bio-Rad, Hercules, CA) of immuno-reactive protein bands. 211 
Image analysis (Quantity One, version 4.; Bio-Rad) was used to measure the relative abundances of target 212 
proteins. Analysis of phosphorylated and non-phosphorylated species was achieved by stripping (incubation 213 
 in 62.5 mM Tris, 70 mM SDS, 50 mM β-mercaptoethanol, pH 6.8 at 50 °C for 30 min) and re-probing of 214 
membranes.  215 
216 
 3. Results 217 
Three independent groups (n= 6, in each) of rats were used to investigate the time course of changes in the 218 
heart phosphoproteome in response to a standardised bout of endurance exercise. The body weight or heart 219 
weight of rats assigned to the control, 0 h and 3 h groups was similar and rats that performed the incremental 220 
exercise test (i.e. 0 h and 3 h groups) had equivalent peak exercise capacities (Table 1). An example of VO2 221 
VCO2 traces recorded during an incremental exercise test is illustrated in Figure 1. The average time to 222 
complete the incremental exercise test was 21 min and the average VO2peak of animals in the 0 h and 3 h 223 
groups was 66 ± 5 ml•kg-1•min-1 and 69.8 ± 5 ml•kg-1•min-1, respectively.   224 
LC-MS/MS profiled 1,169 phosphopeptides and there were 841 singly phosphorylated peptides were detected 225 
and of these 11 were pY, 90 were pT and 840 were pS. There were also 289 doubly phosphorylated peptides, 226 
30 triply phosphorylated and 10 peptides that had between 4 and 6 phosphorylated residues. One-way 227 
ANOVA found 141 peptide differences at P<0.05, the false discovery rate (FDR) calculated from q values 228 
{Storey 2003} was estimated to be 10 %. Volcano plots are illustrated in Figure 2 to highlight post-hoc 229 
analysis of phosphopeptides that differed between the control and 0 h group (Figure 2A) or between control 230 
and 3 h group (Figure 2B). Immediately after cessation of exercise similar numbers of phosphopeptides were 231 
increased and decreased in abundance compared to control. After 3 h recovery (Figure 2B) the majority of 232 
phosphopeptides were more abundant in exercised hearts compared to control.  233 
The 141 peptides that significantly differed in response to acute exercise mapped to 97 proteins, i.e. some 234 
proteins had more than one phosphopeptide. Examples of proteins that had multiple phosphorylated peptides 235 
include titin (10 peptides), tensin (5 peptides), Bcl2-interacting death suppressor (5 peptides), alpha-2-HS-236 
glycoprotein (4 peptides), pyruvate dehydrogenase E1 component subunit alpha (4 peptides) and isoform 2 of 237 
NDRG2 protein (3 peptides).  238 
Exercise-responsive phosphopeptides were uploaded to David GO for functional annotation and the top 239 
ranking significant (P<0.05; Fischer with BH correction) KEGG pathways were arrhythmogenic right 240 
ventricular cardiomyopathy, cardiac muscle contraction and adrenergic signalling in cardiomyocytes.  241 
 Mapping to PhosphoSitePlus (http://www.phosphosite.org) found all but 4 (97 %) of the identified 242 
phosphopeptides had previously been reported. The most commonly reported phosphosites matching to 243 
published high-throughput (MS2) data were pyruvate dehydrogenase E1 component subunit alpha 244 
S232&S239, gap junction alpha-1 protein S325& S328, septin-2 S218 and heat shock protein beta-1 S15. 245 
Approximately 28 % (39 of 141) of the exercise-responsive phosphorylation sites were also associated with 246 
low-throughput experimental evidence in PhosphoSitePlus, including p38 mitogen-activated protein kinase 247 
Y182, cardiac phospholamban S16, alpha B-crystalin S59 and cardiac troponin I S23. Western blot analysis of 248 
phosphorylated and non-phosphorylated forms of p38 MAPK and alpha B crystallin (Figure 3) verified 249 
statistically significant differences in the phosphorylation status of these proteins discovered by LC-MS/MS 250 
phosphopeptide profiling. 251 
The time-series experimental design was used to provide further associational evidence between 252 
phosphorylation events and the cardiac exercise response. Hierarchical cluster analysis was performed in 253 
GProX to find similarities in the temporal patterns of exercise responsive phosphopeptides (n = 141, P<0.05). 254 
The temporal responses in phosphopeptide abundance organised in to 3 prominent clusters (Figure 4A). Gene 255 
identifiers of exercise responsive phosphoproteins from each cluster were uploaded to STRING and Panels B, 256 
C and D of Figure 4 illustrate interaction networks within each cluster based on literature and database 257 
information, including co-expression, protein-protein interaction and literature mining.  258 
259 
 4. Discussion 260 
The mediators of exercise-induced cardiac adaptation have been less thoroughly investigated than the 261 
mechanisms of pathological cardiac maladaptation, but greater knowledge regarding the physiological 262 
responses of the heart could provide a valuable contrast to data from pathological models. To address this 263 
need, we performed phosphoproteomic profiling to generate new knowledge regarding the cardiac 264 
phosphoproteome response to exercise. To minimise potential mis-identification of phosphorylation events 265 
that may be associated with a supra-physiological cardiac stress rather than the response to physiological 266 
exercise, the oxygen uptake (Figure 1) of each animal was monitored and the exercise test was terminated at a 267 
standardised physiological end point (VO2peak). We discovered entirely new phosphorylation sites on 4 268 
cardiac proteins (Table 2), including S81 of muscle LIM protein, and identified 7 exercise-responsive kinases 269 
(Table 3). Almost all (97 %) of the phosphosites that responded significantly to exercise (supplementary Table 270 
S1) were annotated in the PhosphoSitePlus database but, importantly, the majority of these had not previously 271 
been associated with the cardiac response to exercise. Therefore the current data provides a rich source of new 272 
information relating to the potential mediators of exercise-induced cardiac protection.  273 
Muscle LIM protein (MLP; also known as cysteine and glycine-rich protein 3) is an essential component of 274 
myogenic differentiation {Arber 1994} and contains 2 LIM domains which facilitate protein-protein 275 
interactions. LIM domain containing proteins are important mediators of signals between the cytoskeleton and 276 
nucleus {Kadrmas 2004} and we discovered a new phosphorylation of S81 (significantly greater 3 h after 277 
exercise) which lies within a flexible region between LIM domain 1 (residues 10-61) and LIM domain 2 278 
(residues 120-171) of MLP and is close to a previously reported site (S95) that is phosphorylated during beta-279 
1 AR stimulation {Lundby 2013}. Other phosphorylation sites of rat MLP include S111 and S153 but 280 
phosphorylation/ de-phosphorylation of these sites has not yet been linked to environmental stimuli or cell 281 
signalling processes. MLP can interact with a number of myogenic factors {Kong 1997} and also proteins at 282 
the myofibril z-disc, including alpha-actinin {Geier 2003}, beta-spectrin {Flick 2000} and the titin capping 283 
protein, telethonin/ TCAP {Knöll 2002}. Translocation of MLP from the sarcomere to the nucleus is 284 
facilitated by a nuclear localisation signal (residues 64-69) and inhibition of MLP nuclear translocation 285 
prevents the protein synthetic response to cyclic strain in cardiomyocytes {Boateng 2009}.  286 
 We speculate MLP may also be involved in transducing signals in response to exercise in vivo and the novel 287 
S81 phosphorylation reported here may influence the protein-protein interactions and subcellular localisation 288 
of MLP. The amino acid sequence flanking S81 of MLP (Table 1) does not match the linear motifs recognised 289 
by well-defined protein kinases, but our phosphoproteome profiling identified a selection of exercise-290 
responsive myofibrillar protein kinases (Tables 2 and 3) that could be potential mediators of MLP S81 291 
phosphorylation at the z-disc. Two novel exercise-induced phosphorylation events (Table 2) were discovered 292 
on myofibrillar protein kinases (myosin light chain kinase 3 and obscurin) and may be involved in the 293 
transduction of mechanical signals within the exercised heart. Myosin light chain kinase 3 is responsible for 294 
the phosphorylation of ventricular regulatory myosin light chain, which contributes to the enhancement of 295 
myocardial contractility {Kampourakis 2016} and we report novel S444 phosphorylation of myosin light 296 
chain kinase 3 occurs during vigorous exercise (Cluster 1).  297 
Obscurin is also a member of the myosin light chain kinase family along with striated muscle-specific 298 
serine/threonine kinase (SPEG; Table 3) and these kinases are predicted to target similar conserved sites 299 
{Sutter 2004} and may be involved in the hypertrophic response of the heart {Borisov 2006}. In exercised 300 
hearts, we discovered greater phosphorylation of obscurin S2974, which has not previously been reported, and 301 
phosphorylation of SPEG S2410 & S2414 that was reported {Lundby 2013} in phosphoproteome profiling of 302 
the cardiac response to β1-adrenergic receptor (AR) stimulation. Phosphorylation of SPEG has also recently 303 
been reported {Potts 2017} in phosphoproteome analysis of mouse skeletal muscle submitted to a bout of 304 
maximal isometric contractions. These independent discoveries of SPEG phosphorylation using non-targeted 305 
techniques provide reciprocal verification and further highlight SPEG as an exercise-responsive 306 
phosphoprotein/ kinase of interest for future mechanistic study. Phosphorylation of the giant myofibrillar 307 
protein kinase, titin, was also detected after exercise (Table 3) and each of the titin phosphorylation sites 308 
reported here (Table S1) is also known to be responsive to β1-AR stimulation. Taken together, our data 309 
describe a collection of myofibrillar protein kinases and phosphorylation events associated with the z-disc 310 
region that are responsive exercise and warrant further investigation as mediators of exercise-induced cardiac 311 
adaptation. 312 
 Exercise training has protective effects against cardiomyocyte death and proteins that interact with Bcl-2 313 
family members involved in the regulation of apoptosis and autophagy were enriched amongst the exercise-314 
responsive phosphoproteome. We discovered new phosphorylation sites (T93 and Y94; Table 1) on Bcl-2 315 
interacting killer-like protein (Bik) which became significantly more phosphorylated 3 h after cessation of 316 
exercise. These sites are different to the previously reported  ERK1/2 mediated phosphorylation of Bik at 317 
T124 that is associated with ubiquitination and subsequent degradation of Bik {Lopez 2012} and represent 318 
new targets for further exploration. Phosphorylation of BCL2/adenovirus E1B 19 kDa-interacting protein 3 319 
(BNIP3) was increased after exercise and this protein has been implicated in the regulation of both apoptosis 320 
and mitophagy {Choe 2015} in a manner similar to the better characterised protein Beclin-1 {Maejima 2016}. 321 
In addition, exercise was associated with phosphorylation of Bcl-2-interacting death suppressor (Bag3) on 322 
sites (S176, S277, S278, S377, S387)  previously reported in response to beta-adrenergic receptor stimulation 323 
{Lundby 2013}.  Bag3 is a co-chaperone of heat shock cognate 70 (hsc70), interacts with heat shock protein 324 
22 and regulates the interaction with poly-glutamate (Poly-Q) proteins which are prone to aggregation. 325 
Phosphorylation of S397 of Bcl-2 associated transcription factor 1 (BCLAF1) increased after cessation of the 326 
exercise (cluster 3) and this protein is required for efficient DNA repair and genome stability {Savage 2014}. 327 
Together our findings describe an unappreciated network of responses in proteins that regulate apoptosis and 328 
autophagy processes, beyond the more widely reported effector proteins such as Bcl-2 and Bax. 329 
During exercise myocardial contractility increases to meet the greater demand for cardiac output and this 330 
response is in part driven by β-AR signalling. Approximately one-third (41 of 141 phosphopeptides) of the 331 
exercise-responsive phosphopeptides were previously identified in similar phosphoproteome profiling 332 
{Lundby 2013} of the cardiac response to β1-AR stimulation, including PKA and archetypal proteins involved 333 
in myocardial contractility/ Ca2+-handling and metabolism. For example, ryanodine receptor phosphorylation 334 
increased during exercise (Figure 4, Cluster 1) and this has previously been associated with augmentation of 335 
intracellular calcium release and enhanced myocardial contractility {Marx 2000}. The SERCA inhibitor, 336 
phospholamban, was phosphorylated at S16, which is noted to be sufficient for a maximal cardiac response to 337 
β-AR stimulation {Chu 2000}, and in addition, we report phosphorylation of lesser-known proteins such as 338 
histidine-rich calcium binding protein that also regulates SR calcium release {Arvanitis 2011}. With regard to 339 
 metabolism, exercise increased S694 phosphorylation of phosphorylase kinase beta (Table 3) which is 340 
responsible for phosphorylation of glycogen phosphorylase and therefore acceleration of glycogenolysis. The 341 
monocarboxylate transporter 1 (Slc161a) was also phosphorylated at a β1-AR responsive site immediately 342 
after exercise and this may be associated the transport lactate or ketones in to cardiac muscle cells. 343 
Conversely, phosphorylation of the pyruvate dehydrogenase E1 complex subunit alpha (Pdha1) is associated 344 
with inhibition of pyruvate entry to the TCA cycle and was increased 3 h after the cessation of exercise 345 
(Figure 4, Cluster 3) and may be more associated with restoration of cardiac glycogen stores. Notably, 346 
phosphorylation sites reported here in response to exercise and by Lundby et al {Lundby 2013} in response to 347 
β1-AR stimulation do not entirely overlap, and even after taking in to account potential technical differences 348 
between the 2 studies, it is evident that the cardiac exercise response is not entirely driven by β1-AR 349 
stimulation. 350 
Cardiac β1-AR stimulation is associated with the activation of p38 MAP kinase {Lundby 2013} and this was 351 
also detected in response to exercise (Table 3 and Figure 3A). Previous {Hunter 2008} targeted (western blot) 352 
analysis of signalling proteins in hearts of high- and low-capacity runner rats isolated 10 min after performing 353 
a ramped treadmill test measured a 1.6-fold increase in p38 MAPK (T180/Y182) phosphorylation, which is 354 
corroborated by our data (Figure 3A). We further show Y182-specific phosphorylation of p38 MAPK 355 
(measured by LC-MS; Table S1) is transient and was not significantly different from control 3 h after 356 
exercise. Moreover the change in p38 MAPK phosphorylation clusters with the phosphorylation of proteins 357 
including alpha B-crystallin, heat shock protein 27 and astrocytic phosphoprotein PEA-15 (Figure 4; Cluster 358 
1). Astrocytic phosphoprotein PEA-15 modulates the localisation and activity of ERK 1/2 MAP Kinases 359 
(MAPK1 and MAPK3), phosphorylation of PEA-15 at both S104 and S106 is necessary and sufficient to 360 
prevent its interaction with ERK 1/2 whereas non-phosphorylated PEA-15 blocks the nuclear translocation 361 
and transcriptional capacity of ERK 1/2 {Krueger 2005}. In the current work PEA-15 was phosphorylated at 362 
S104 only, but nonetheless the exercise-responsive phosphoproteome was enriched for proteins involved in 363 
ERK1/2 mitogen-activated protein kinases pathway and approximately 18 % (25 of 141) of the cardiac 364 
phosphorylation sites reported here have previously been identified as ERK1/2 targets by phosphoproteomic 365 
analysis of epithelia cells {Courcelles 2013}.  366 
 MEK1-ERK1/2 signalling can inhibit Clacineurin-NFAT signalling which is strongly implicated in 367 
pathological cardiac hypertrophy {Molkentin 2004}. Given the large degree of cross-talk between these 368 
pathways more intricate studies are needed to decipher the networks of interactions associated with 369 
pathological versus physiological cardiac adaptations, and the role of currently lesser known components such 370 
as Cyma5 costamere protein, which was phosphorylated in response to exercise, and is a negative regulator of 371 
calcineurin-NFAT signalling cascade {Molkentin 2004} will need to be integrated with the existing canonical 372 
pathways.  373 
The IGF-1 receptor/PI3K (p110α)/ Akt1 pathway is the most thoroughly studied signalling pathway 374 
associated with exercise-induced cardiac adaptation and is associated with Akt S473 phosphorylation {Weeks 375 
2012}. We found no significant change in Akt S473 phosphorylation after an acute bout of treadmill running 376 
which is consistent with previous {Hunter 2008} findings and suggests a single exercise bout is not sufficient 377 
to instigate the IGF-1 receptor signalling in the heart. Nonetheless, acute exercise was associated with 378 
phosphorylation of direct regulators of ribosomal translation such as eukaryotic initiation factors eIF2 and 379 
eIF5. The interaction between eIF-5B and eIF2β is essential for GTP hydrolysis and release of eIF2-GDP 380 
from the 40 S initiation complex and the formation of the 80 S ribosome. Phosphorylation of eIF2 clustered 381 
with ATP-binding cassette sub-family F member 1 (ABCF1) and this interaction (including S109 382 
phosphorylation of ABCF1) has previously been reported to be necessary in both cap-dependent and 383 
independent translation {Paytubi 2009}. Therefore our findings draw attention to regulators of ribosomal 384 
translation initiation that have largely been ignored in previous exercise-related studies. 385 
A single bout of exercise can precondition the heart against I/R damage {Frasier 2011} and gap junction 386 
proteins could be a key mechanism underlying this protective effect {Jeyaraman 2012}. Gap junction alpha-1 387 
protein (Cx43) is the main component of gap junctions in the ventricular myocardium and phosphorylation of 388 
S325, S328 and T326 of Cx43 increased 3 h after exercise. Cx43 has a short (<5 h) half-life and 389 
phosphorylation is required for gap junction formation whereas de-phosphorylation is associated with the 390 
disassembly of the gap junction and Cx43 degradation {Solan 2007}. Phosphorylation at 325, 328 and 330 391 
reported here may be mediated by casein kinase 1{Cooper 2002} or fibroblast growth factor {Sakurai 2013} 392 
and regulate gap junction assembly {Lampe 2006}. In contrast, Cx43 S262 phosphorylation has more 393 
 commonly been associated with cardiac preconditioning mediated via PKC {Waza 2014} and was not 394 
responsive to exercise. Therefore the current findings highlight a novel exercise-induced mechanism 395 
involving gap-junction assembly/ turnover separate from those involved in ischaemic preconditioning. In 396 
addition, phosphorylation of CX43 co-occurred with the phosphorylation of tight junction protein 2, 397 
Palkophillin-2 and the alpha subunit of the voltage-gated sodium channel (Figure 4, Cluster 3), which have 398 
previously been reported as interaction partners. 399 
400 
 5. Summary 401 
Signal transduction is a dynamic process and we used a time-series design to dissect immediate/early events 402 
such as phospholamban phosphorylation (Figure 4; Cluster 1), which may be more associated with myocardial 403 
contractility, from sustained (Figure 4; Cluster 2) or latter (Figure 4; Cluster 3) phosphorylation events that 404 
may be more associated with the adaptive response to exercise or the restoration of cardiac homeostasis. Non-405 
targeted analysis detected well established phosphorylation events associated with myocardial contractility 406 
whilst simultaneously detecting new site-specific phosphorylation events on proteins that are not shared with 407 
the cardiac response to β1-AR stimulation and have not previously been associated with the cardiac exercise 408 
response. In particular, we discovered new phosphorylation sites on 4 cardiac proteins (Table 2), including 409 
S81 of muscle LIM protein, and identified a selection of myofibrillar protein kinases that were also responsive 410 
to exercise and may constitute a putative network of signal transduction for the adaptation to mechanical work 411 
in the heart. 412 
413 
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 Table 1 – Physical and physiological characteristics  422 
 Control 0 h 3 h 
Body weight (g) 338 ± 16 350 ± 27 351 ± 9 
Heart weight (mg) 1071 ± 44 1005 ± 76 1060 ± 40 
VO2peak (ml•kg-1•min-1)  66 ± 5 69.8 ± 5 
Peak RER  1.046 ± 0.03 1.021 ± 0.03 
Time to completion (min)  21.3 ± 3.6 21.3 ± 3.1 
Data are presented as Mean ± SD (n = 6, in each group). There were no statistically significant (p<0.05) differences between the groups for any 423 
of the variables measured. 424 
 425 
 426 
 427 
  428 
Table 2 – New site-specific phosphorylation sites discovered in cardiac proteins 429 
Cluster Protein name UniProt Residue (+/-)7 Sequence 
1 Myosin light chain kinase 3 E9PT87 S444 TEAGRRVSpSAAEAAI 
2 Obscurin A0A0G2K8N1 S2974 LGLTSKASpLKDSGEY 
3 Cysteine and glycine-rich protein 3 P50463 S81 GQGAGCLSpTDTGEHL 
3 Bcl2-interacting killer-like protein Q925D2 T93 & Y94 MHRLAATpYpSQTGVR 
 430 
 431 
 432 
 433 
 Table 3 – Phosphorylated kinase enzymes 434 
Cluster Protein name UniProt Residue 
1 Myosin light chain kinase 3 E9PT87 S444 
1 p38 mitogen-activated protein kinase Q56A33 Y182 
1 Phosphorylase kinase beta Q5RKH5 S694 
1 Titin Q9JHQ1 S402 
1 Titin Q9JHQ1 S1990 
2 cAMP-dependent protein kinase P09456 S77 & S83 
2 Obscurin A0A0G2K8N1 S2974 
2 Striated muscle specific serine/threonine kinase Q63638 S2410 & S2414 
2 Titin Q9JHQ1 S256 & T267 
2 Titin Q9JHQ1 S32863 
3 cAMP-dependent protein kinase P09456 S83 
3 Titin Q9JHQ1 T300 & S302 
3 Titin Q9JHQ1 S1332 & S1336 
 435 
 436 
 437 
 438 
 439 
 Figure Legends 440 
Figure 1 - Measurement of VO2peak 441 
Example oxygen uptake (VO2) and carbon dioxide production (VCO2) traces during an incremental 442 
exercise test designed to elicit peak oxygen uptake (VO2peak).  443 
 444 
Figure 2 - Changes in the abundance of exercise responsive phosphopeptides 445 
Volcano plots presenting the distribution of the fold-change (log2) in abundance and statistical 446 
significance of phosphorylated peptides. Post-hoc comparisons are shown for (A) non-exercised 447 
control hearts vs hearts isolated immediately (0 h) after cessation of the graded exercise test, or (B) 448 
non-exercised control hearts vs hearts isolated 3 h after cessation of the graded exercise test.  449 
 450 
Figure 3 – Exercise responsive phosphorylation of cardiac p38 MAPK and CRYAB 451 
Western blot analysis of the ratio of phosphorylated: non-phosphorylated p38 mitogen activated 452 
kinase (p38 MAPK; A) and alpha B crystallin (CRYAB; B). Cropped images of 3 representative lanes 453 
from a single animal from the control, 0 h and 3 h groups are shown. Data are presented as mean ± 454 
SEM (n = 6, per group) and statistical significance (*P<0.05 different from control group) was 455 
determined by one-way analysis of variance and Tukey HSD post-hoc analysis.  456 
 457 
Figure 4 – Hierarchal clustering of exercise responsive phosphopeptides 458 
Unsupervised hierarchal clustering was performed on 141 phosphopeptides that exhibited statistically 459 
significant (P<0.05) differences across time by one-way ANAVO. Known and predicted interactions 460 
between proteins within each cluster were then investigated using the Search Tool for the Retrieval of 461 
Interacting Genes/Proteins (STRING). (A) Cluster 1 contains phosphopeptides whose abundance 462 
significantly increased immediately after exercise and then returned to basal levels within 3 h after 463 
cessation of the exercise test; this cluster included phosphorylation of phospholamban (Pln) and a 464 
network of p38α (MAPK14) stress-responsive proteins including alpha B-crystallin (Cryab) and heat 465 
 shock 27 kDa protein (Hspb1). (B) Cluster 2 contains phosphopeptides whose abundance increased 466 
immediately after exercise and further increased 3 h after cessation of the exercise test; this cluster 467 
included phosphorylation of costamere and gap junction proteins such as vincullin and connexion 43 468 
(Gja1). In addition, ribosomal proteins, such as eukaryotic initiation factor 2 (eIF2s2) and ATP 469 
binding cassette sub-family F member 1 (Abcf1), which regulate both cap-dependent and independent 470 
translation were phosphorylated in response to exercise. (C) Cluster 3 contains phosphopeptides 471 
whose abundance decreased immediately after exercise and then returned to basal levels within 3 h 472 
after cessation of the exercise test; this cluster included phosphorylation of myofibrillar proteins, 473 
including muscle LIM protein (Csrp3). 474 
475 
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